Clinical Trials
- Heart/Cardiovascular
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after Coronary Artery Bypass Surgery
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- Ages1 year - 70 years
- GenderBoth
- Heart/Cardiovascular
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
- Ages18 years and older
- GenderBoth